GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Propanc Biopharma PPCB · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.76

-0.56%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Propanc Biopharma — daily PPCB Delayed
Market value
$2,464
Last close × shares
Volume
15.3k
Shares, 9 Nov 2026

About Propanc Biopharma

From its filings with the US Securities and Exchange Commission

SEC filings

Propanc Biopharma is based in Camberwell, Victoria, Australia and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker PPCB. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 30 June 2026, it reported a net loss of $18.9m. At that date it held total assets of $12.8m and shareholders' equity of $9.4m.

Read the filing on SEC.gov ↗

More about Propanc Biopharma →

Latest on Propanc Biopharma

Our reporting

We have not reported on Propanc Biopharma yet.

Next results

13 Nov 2026

Due on 13 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Propanc Biopharma's ticker?

Propanc Biopharma trades as PPCB on its US listing, under ISIN US74346N7012.

What was Propanc Biopharma's last closing price?

1.76 on 9 Nov 2026. The figure is in USD and is never converted.

When does Propanc Biopharma next report results?

Results are expected on 13 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.